

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | defense response to fungus (GO:0050832) | 9.83699678 |
| 2 | killing of cells of other organism (GO:0031640) | 9.55021153 |
| 3 | disruption of cells of other organism (GO:0044364) | 9.55021153 |
| 4 | innate immune response in mucosa (GO:0002227) | 8.67518675 |
| 5 | antibacterial humoral response (GO:0019731) | 8.24931677 |
| 6 | mucosal immune response (GO:0002385) | 7.63663883 |
| 7 | antimicrobial humoral response (GO:0019730) | 7.52663634 |
| 8 | organ or tissue specific immune response (GO:0002251) | 7.10630363 |
| 9 | response to fungus (GO:0009620) | 7.03417878 |
| 10 | leukocyte migration involved in inflammatory response (GO:0002523) | 5.33782424 |
| 11 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 5.26368013 |
| 12 | cellular extravasation (GO:0045123) | 5.18352803 |
| 13 | oxygen transport (GO:0015671) | 5.07974746 |
| 14 | cell killing (GO:0001906) | 5.03285448 |
| 15 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.99077746 |
| 16 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.99077746 |
| 17 | response to peptidoglycan (GO:0032494) | 4.95822128 |
| 18 | detection of bacterium (GO:0016045) | 4.84790502 |
| 19 | detection of other organism (GO:0098543) | 4.77426238 |
| 20 | neutrophil activation (GO:0042119) | 4.64421967 |
| 21 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.56971528 |
| 22 | superoxide anion generation (GO:0042554) | 4.54198728 |
| 23 | negative regulation of interleukin-8 production (GO:0032717) | 4.44658904 |
| 24 | neutrophil activation involved in immune response (GO:0002283) | 4.27420716 |
| 25 | granulocyte activation (GO:0036230) | 4.17073586 |
| 26 | defense response to Gram-positive bacterium (GO:0050830) | 4.14776787 |
| 27 | activated T cell proliferation (GO:0050798) | 4.10914690 |
| 28 | gas transport (GO:0015669) | 4.04551251 |
| 29 | L-fucose catabolic process (GO:0042355) | 4.04025855 |
| 30 | fucose catabolic process (GO:0019317) | 4.04025855 |
| 31 | L-fucose metabolic process (GO:0042354) | 4.04025855 |
| 32 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.99532251 |
| 33 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.94205969 |
| 34 | negative regulation of growth of symbiont in host (GO:0044130) | 3.88294519 |
| 35 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.88294519 |
| 36 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.88294519 |
| 37 | regulation of growth of symbiont in host (GO:0044126) | 3.88294519 |
| 38 | negative regulation of interleukin-6 production (GO:0032715) | 3.82821264 |
| 39 | leukocyte aggregation (GO:0070486) | 3.82625318 |
| 40 | defense response to bacterium (GO:0042742) | 3.70244596 |
| 41 | negative regulation of mast cell activation (GO:0033004) | 3.66955810 |
| 42 | behavioral response to nicotine (GO:0035095) | 3.56847090 |
| 43 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.48722597 |
| 44 | regulation of natural killer cell differentiation (GO:0032823) | 3.47798425 |
| 45 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.45075350 |
| 46 | regulation of mast cell activation (GO:0033003) | 3.39164233 |
| 47 | regulation of female gonad development (GO:2000194) | 3.35577113 |
| 48 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.32533485 |
| 49 | response to host immune response (GO:0052572) | 3.32533485 |
| 50 | imidazole-containing compound metabolic process (GO:0052803) | 3.32333474 |
| 51 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 3.31779370 |
| 52 | response to methylmercury (GO:0051597) | 3.30725866 |
| 53 | phagosome maturation (GO:0090382) | 3.28371723 |
| 54 | hemoglobin metabolic process (GO:0020027) | 3.25902645 |
| 55 | response to bacterium (GO:0009617) | 3.21972925 |
| 56 | positive regulation of steroid hormone secretion (GO:2000833) | 3.19632194 |
| 57 | detection of external biotic stimulus (GO:0098581) | 3.18860327 |
| 58 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.12072596 |
| 59 | mast cell activation (GO:0045576) | 3.06771586 |
| 60 | porphyrin-containing compound biosynthetic process (GO:0006779) | 3.06206526 |
| 61 | respiratory burst (GO:0045730) | 3.03677451 |
| 62 | adaptation of signaling pathway (GO:0023058) | 3.01730635 |
| 63 | tetrapyrrole biosynthetic process (GO:0033014) | 2.99697211 |
| 64 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.95238117 |
| 65 | leukocyte degranulation (GO:0043299) | 2.88079560 |
| 66 | detection of biotic stimulus (GO:0009595) | 2.86085521 |
| 67 | negative regulation of interleukin-1 production (GO:0032692) | 2.82992001 |
| 68 | leukotriene biosynthetic process (GO:0019370) | 2.82290862 |
| 69 | citrulline biosynthetic process (GO:0019240) | 2.76865834 |
| 70 | regulation of mast cell degranulation (GO:0043304) | 2.72694438 |
| 71 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.72147925 |
| 72 | bicarbonate transport (GO:0015701) | 2.71379852 |
| 73 | cytidine metabolic process (GO:0046087) | 2.70689430 |
| 74 | cytidine catabolic process (GO:0006216) | 2.70689430 |
| 75 | cytidine deamination (GO:0009972) | 2.70689430 |
| 76 | neutrophil chemotaxis (GO:0030593) | 2.70508708 |
| 77 | modification of morphology or physiology of other organism (GO:0035821) | 2.70042059 |
| 78 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.69213387 |
| 79 | positive regulation of mast cell activation (GO:0033005) | 2.69147365 |
| 80 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.68921871 |
| 81 | response to host (GO:0075136) | 2.68921871 |
| 82 | response to host defenses (GO:0052200) | 2.68921871 |
| 83 | regulation of feeding behavior (GO:0060259) | 2.68573851 |
| 84 | myeloid cell development (GO:0061515) | 2.68525366 |
| 85 | erythrocyte maturation (GO:0043249) | 2.68019199 |
| 86 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.64230753 |
| 87 | neutrophil migration (GO:1990266) | 2.64010249 |
| 88 | neutrophil mediated immunity (GO:0002446) | 2.62735876 |
| 89 | cell wall macromolecule catabolic process (GO:0016998) | 2.62623679 |
| 90 | regulation of interleukin-8 production (GO:0032677) | 2.60948095 |
| 91 | regulation of memory T cell differentiation (GO:0043380) | 2.60120592 |
| 92 | hydrogen peroxide catabolic process (GO:0042744) | 2.59380139 |
| 93 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.58653478 |
| 94 | erythrocyte development (GO:0048821) | 2.58327071 |
| 95 | heme biosynthetic process (GO:0006783) | 2.57921629 |
| 96 | negative regulation of telomere maintenance (GO:0032205) | 2.57739014 |
| 97 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.57689261 |
| 98 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.57450969 |
| 99 | granulocyte migration (GO:0097530) | 2.48077713 |
| 100 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.46814792 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.37342138 |
| 2 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.07743023 |
| 3 | VDR_22108803_ChIP-Seq_LS180_Human | 2.99829981 |
| 4 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.70692081 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.61822403 |
| 6 | GATA1_22025678_ChIP-Seq_K562_Human | 2.45599757 |
| 7 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.30961149 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.19286063 |
| 9 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.15883618 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.01726118 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.98949484 |
| 12 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.94648512 |
| 13 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.89208141 |
| 14 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.89050375 |
| 15 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.83262893 |
| 16 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.80296397 |
| 17 | GATA1_19941826_ChIP-Seq_K562_Human | 1.74910294 |
| 18 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.73671063 |
| 19 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.73049412 |
| 20 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.72123970 |
| 21 | GATA3_26560356_Chip-Seq_TH2_Human | 1.69846740 |
| 22 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.68529778 |
| 23 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.66386993 |
| 24 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.63311852 |
| 25 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.61104730 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.58075412 |
| 27 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.53640024 |
| 28 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.53075716 |
| 29 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.52472208 |
| 30 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.49567340 |
| 31 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.48001124 |
| 32 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.46605040 |
| 33 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.44597825 |
| 34 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.44597825 |
| 35 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.43692055 |
| 36 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.43391162 |
| 37 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.42537946 |
| 38 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.39329437 |
| 39 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.37822931 |
| 40 | AR_20517297_ChIP-Seq_VCAP_Human | 1.37762997 |
| 41 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36371437 |
| 42 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.36112031 |
| 43 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.35774582 |
| 44 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.31252521 |
| 45 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.30651124 |
| 46 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29919633 |
| 47 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.29169689 |
| 48 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28400335 |
| 49 | P300_19829295_ChIP-Seq_ESCs_Human | 1.27484493 |
| 50 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.26567195 |
| 51 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.26452345 |
| 52 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.26272991 |
| 53 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.25464188 |
| 54 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.23137820 |
| 55 | EWS_26573619_Chip-Seq_HEK293_Human | 1.21528111 |
| 56 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.20954262 |
| 57 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.20464918 |
| 58 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.19993244 |
| 59 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.19749858 |
| 60 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.19556941 |
| 61 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.17857435 |
| 62 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.17827472 |
| 63 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.17827472 |
| 64 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17346465 |
| 65 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.16338627 |
| 66 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.16303037 |
| 67 | GATA2_19941826_ChIP-Seq_K562_Human | 1.16165863 |
| 68 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.13752489 |
| 69 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13396411 |
| 70 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.11853150 |
| 71 | NCOR_22424771_ChIP-Seq_293T_Human | 1.10362879 |
| 72 | MYB_26560356_Chip-Seq_TH2_Human | 1.10046626 |
| 73 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.09371433 |
| 74 | * SMRT_27268052_Chip-Seq_Bcells_Human | 1.09227188 |
| 75 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07283115 |
| 76 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.06550091 |
| 77 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.05480397 |
| 78 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.03828739 |
| 79 | ERA_21632823_ChIP-Seq_H3396_Human | 1.03517724 |
| 80 | STAT3_23295773_ChIP-Seq_U87_Human | 1.03078795 |
| 81 | * OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.02542872 |
| 82 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.02298905 |
| 83 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.01941776 |
| 84 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.01738531 |
| 85 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.01346055 |
| 86 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.01283565 |
| 87 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.00586075 |
| 88 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.99704407 |
| 89 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99529073 |
| 90 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.98392494 |
| 91 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.97416409 |
| 92 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.96732002 |
| 93 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.96616737 |
| 94 | FUS_26573619_Chip-Seq_HEK293_Human | 0.96488748 |
| 95 | GATA3_26560356_Chip-Seq_TH1_Human | 0.95747563 |
| 96 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.95546934 |
| 97 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95546934 |
| 98 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.94508555 |
| 99 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.93948986 |
| 100 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.93872110 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004147_increased_porphyrin_level | 4.67117674 |
| 2 | MP0003656_abnormal_erythrocyte_physiolo | 3.30226597 |
| 3 | MP0003724_increased_susceptibility_to | 2.92067015 |
| 4 | MP0009785_altered_susceptibility_to | 2.89219077 |
| 5 | MP0001986_abnormal_taste_sensitivity | 2.38637468 |
| 6 | MP0003303_peritoneal_inflammation | 2.37645540 |
| 7 | MP0000569_abnormal_digit_pigmentation | 2.35868116 |
| 8 | MP0002419_abnormal_innate_immunity | 2.34597885 |
| 9 | MP0005025_abnormal_response_to | 2.31692505 |
| 10 | MP0000685_abnormal_immune_system | 2.23247178 |
| 11 | MP0003436_decreased_susceptibility_to | 2.22205969 |
| 12 | MP0003011_delayed_dark_adaptation | 2.17236994 |
| 13 | MP0003172_abnormal_lysosome_physiology | 2.10197692 |
| 14 | MP0002138_abnormal_hepatobiliary_system | 2.09841267 |
| 15 | MP0005083_abnormal_biliary_tract | 1.97884796 |
| 16 | MP0003195_calcinosis | 1.77701005 |
| 17 | MP0005075_abnormal_melanosome_morpholog | 1.75791799 |
| 18 | MP0003646_muscle_fatigue | 1.70952473 |
| 19 | MP0001835_abnormal_antigen_presentation | 1.69672007 |
| 20 | MP0005174_abnormal_tail_pigmentation | 1.68661766 |
| 21 | MP0005464_abnormal_platelet_physiology | 1.67060533 |
| 22 | MP0005671_abnormal_response_to | 1.65927617 |
| 23 | MP0008872_abnormal_physiological_respon | 1.65386896 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 1.63794010 |
| 25 | MP0009764_decreased_sensitivity_to | 1.60023873 |
| 26 | MP0001800_abnormal_humoral_immune | 1.59273194 |
| 27 | MP0005387_immune_system_phenotype | 1.58882577 |
| 28 | MP0001790_abnormal_immune_system | 1.58882577 |
| 29 | MP0002420_abnormal_adaptive_immunity | 1.55116762 |
| 30 | MP0001819_abnormal_immune_cell | 1.54123185 |
| 31 | MP0005000_abnormal_immune_tolerance | 1.48881116 |
| 32 | MP0002452_abnormal_antigen_presenting | 1.48565068 |
| 33 | MP0002095_abnormal_skin_pigmentation | 1.48561253 |
| 34 | MP0005084_abnormal_gallbladder_morpholo | 1.48350940 |
| 35 | MP0008877_abnormal_DNA_methylation | 1.48333415 |
| 36 | MP0000015_abnormal_ear_pigmentation | 1.43463687 |
| 37 | MP0002723_abnormal_immune_serum | 1.42954008 |
| 38 | MP0009046_muscle_twitch | 1.40263547 |
| 39 | MP0004142_abnormal_muscle_tone | 1.36766921 |
| 40 | MP0009278_abnormal_bone_marrow | 1.36005787 |
| 41 | MP0002102_abnormal_ear_morphology | 1.34170430 |
| 42 | MP0005551_abnormal_eye_electrophysiolog | 1.30815591 |
| 43 | MP0005397_hematopoietic_system_phenotyp | 1.29343672 |
| 44 | MP0001545_abnormal_hematopoietic_system | 1.29343672 |
| 45 | MP0008875_abnormal_xenobiotic_pharmacok | 1.26300165 |
| 46 | MP0000689_abnormal_spleen_morphology | 1.24881195 |
| 47 | MP0001533_abnormal_skeleton_physiology | 1.22141531 |
| 48 | MP0001845_abnormal_inflammatory_respons | 1.21966477 |
| 49 | MP0003183_abnormal_peptide_metabolism | 1.17816855 |
| 50 | MP0002398_abnormal_bone_marrow | 1.17604074 |
| 51 | MP0005253_abnormal_eye_physiology | 1.15702196 |
| 52 | MP0004130_abnormal_muscle_cell | 1.15558804 |
| 53 | MP0002405_respiratory_system_inflammati | 1.12774157 |
| 54 | MP0005636_abnormal_mineral_homeostasis | 1.11561518 |
| 55 | MP0000716_abnormal_immune_system | 1.11147564 |
| 56 | MP0005645_abnormal_hypothalamus_physiol | 1.10079293 |
| 57 | MP0002722_abnormal_immune_system | 1.09438252 |
| 58 | MP0009745_abnormal_behavioral_response | 1.07989073 |
| 59 | MP0003045_fibrosis | 1.03862545 |
| 60 | MP0002876_abnormal_thyroid_physiology | 1.03753369 |
| 61 | MP0000465_gastrointestinal_hemorrhage | 1.03091983 |
| 62 | MP0002277_abnormal_respiratory_mucosa | 1.01451326 |
| 63 | MP0001919_abnormal_reproductive_system | 1.00187334 |
| 64 | MP0002837_dystrophic_cardiac_calcinosis | 0.99546016 |
| 65 | MP0001486_abnormal_startle_reflex | 0.98884342 |
| 66 | MP0001968_abnormal_touch/_nociception | 0.97996210 |
| 67 | MP0004742_abnormal_vestibular_system | 0.97153202 |
| 68 | MP0003950_abnormal_plasma_membrane | 0.97059398 |
| 69 | MP0002429_abnormal_blood_cell | 0.96808771 |
| 70 | MP0004885_abnormal_endolymph | 0.94167832 |
| 71 | MP0002733_abnormal_thermal_nociception | 0.92879849 |
| 72 | MP0005310_abnormal_salivary_gland | 0.92834977 |
| 73 | MP0000230_abnormal_systemic_arterial | 0.92582097 |
| 74 | MP0002653_abnormal_ependyma_morphology | 0.92203951 |
| 75 | MP0004145_abnormal_muscle_electrophysio | 0.88316622 |
| 76 | MP0003136_yellow_coat_color | 0.88276803 |
| 77 | MP0001485_abnormal_pinna_reflex | 0.87205787 |
| 78 | MP0008775_abnormal_heart_ventricle | 0.85030933 |
| 79 | MP0005646_abnormal_pituitary_gland | 0.84627645 |
| 80 | MP0001663_abnormal_digestive_system | 0.84055861 |
| 81 | MP0003828_pulmonary_edema | 0.83933111 |
| 82 | MP0001970_abnormal_pain_threshold | 0.83479412 |
| 83 | MP0000371_diluted_coat_color | 0.82209604 |
| 84 | MP0005167_abnormal_blood-brain_barrier | 0.81446075 |
| 85 | MP0002693_abnormal_pancreas_physiology | 0.81256617 |
| 86 | MP0002638_abnormal_pupillary_reflex | 0.80075751 |
| 87 | MP0002064_seizures | 0.79287885 |
| 88 | MP0006082_CNS_inflammation | 0.78636252 |
| 89 | MP0001873_stomach_inflammation | 0.78243567 |
| 90 | MP0000427_abnormal_hair_cycle | 0.78159225 |
| 91 | MP0005410_abnormal_fertilization | 0.77491587 |
| 92 | MP0005448_abnormal_energy_balance | 0.77255690 |
| 93 | MP0009765_abnormal_xenobiotic_induced | 0.76664203 |
| 94 | MP0005389_reproductive_system_phenotype | 0.75689573 |
| 95 | MP0006276_abnormal_autonomic_nervous | 0.74256995 |
| 96 | MP0001764_abnormal_homeostasis | 0.73490287 |
| 97 | MP0005377_hearing/vestibular/ear_phenot | 0.73066506 |
| 98 | MP0003878_abnormal_ear_physiology | 0.73066506 |
| 99 | MP0001324_abnormal_eye_pigmentation | 0.72717347 |
| 100 | MP0010386_abnormal_urinary_bladder | 0.72633372 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypochromic microcytic anemia (HP:0004840) | 7.21739562 |
| 2 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 6.52597487 |
| 3 | Hypochromic anemia (HP:0001931) | 4.41044510 |
| 4 | Stomatitis (HP:0010280) | 4.32604969 |
| 5 | Poikilocytosis (HP:0004447) | 4.02987002 |
| 6 | Microcytic anemia (HP:0001935) | 3.62781705 |
| 7 | Congenital stationary night blindness (HP:0007642) | 3.46073723 |
| 8 | Recurrent abscess formation (HP:0002722) | 3.44740591 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 3.36557766 |
| 10 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.22886993 |
| 11 | Abnormal hemoglobin (HP:0011902) | 3.00854606 |
| 12 | Paralysis (HP:0003470) | 2.89177208 |
| 13 | Pancreatic cysts (HP:0001737) | 2.89102399 |
| 14 | Abolished electroretinogram (ERG) (HP:0000550) | 2.86535269 |
| 15 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.85711933 |
| 16 | Prolonged bleeding time (HP:0003010) | 2.78816621 |
| 17 | Stomach cancer (HP:0012126) | 2.78381380 |
| 18 | Abnormality of midbrain morphology (HP:0002418) | 2.75957154 |
| 19 | Molar tooth sign on MRI (HP:0002419) | 2.75957154 |
| 20 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.69896459 |
| 21 | Abnormality of glycolipid metabolism (HP:0010969) | 2.69896459 |
| 22 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.69896459 |
| 23 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.68221424 |
| 24 | Myositis (HP:0100614) | 2.67798434 |
| 25 | Eczematoid dermatitis (HP:0000976) | 2.58570272 |
| 26 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.56422030 |
| 27 | Abnormality of macrophages (HP:0004311) | 2.55953292 |
| 28 | Abnormality of B cell number (HP:0010975) | 2.55895105 |
| 29 | Retrobulbar optic neuritis (HP:0100654) | 2.54696542 |
| 30 | Optic neuritis (HP:0100653) | 2.54696542 |
| 31 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.52566750 |
| 32 | Hypoplasia of the fovea (HP:0007750) | 2.52566750 |
| 33 | Increased cerebral lipofuscin (HP:0011813) | 2.48905322 |
| 34 | Autoimmune thrombocytopenia (HP:0001973) | 2.48666674 |
| 35 | Recurrent fungal infections (HP:0002841) | 2.48255101 |
| 36 | Abnormality of iron homeostasis (HP:0011031) | 2.48104548 |
| 37 | Chronic obstructive pulmonary disease (HP:0006510) | 2.47543654 |
| 38 | Obstructive lung disease (HP:0006536) | 2.47543654 |
| 39 | Toxemia of pregnancy (HP:0100603) | 2.42232065 |
| 40 | Agitation (HP:0000713) | 2.35805325 |
| 41 | Nephronophthisis (HP:0000090) | 2.34853103 |
| 42 | Decreased central vision (HP:0007663) | 2.34716168 |
| 43 | Recurrent skin infections (HP:0001581) | 2.30657209 |
| 44 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.30508115 |
| 45 | Attenuation of retinal blood vessels (HP:0007843) | 2.28947749 |
| 46 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.28736253 |
| 47 | Decreased circulating renin level (HP:0003351) | 2.25868157 |
| 48 | Progressive cerebellar ataxia (HP:0002073) | 2.24005337 |
| 49 | Mediastinal lymphadenopathy (HP:0100721) | 2.23799960 |
| 50 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.23250386 |
| 51 | True hermaphroditism (HP:0010459) | 2.23099249 |
| 52 | Petechiae (HP:0000967) | 2.21364667 |
| 53 | Large for gestational age (HP:0001520) | 2.17910796 |
| 54 | Pancreatic fibrosis (HP:0100732) | 2.17597134 |
| 55 | Recurrent cutaneous fungal infections (HP:0011370) | 2.16290884 |
| 56 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.16290884 |
| 57 | Keratoconjunctivitis (HP:0001096) | 2.16082455 |
| 58 | Abnormality of the renal cortex (HP:0011035) | 2.15352087 |
| 59 | Abnormal drinking behavior (HP:0030082) | 2.15198853 |
| 60 | Polydipsia (HP:0001959) | 2.15198853 |
| 61 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.14533031 |
| 62 | Absent/shortened dynein arms (HP:0200106) | 2.14533031 |
| 63 | Orchitis (HP:0100796) | 2.12603172 |
| 64 | Hemoptysis (HP:0002105) | 2.09052024 |
| 65 | Pulmonary infiltrates (HP:0002113) | 2.06810849 |
| 66 | Gastrointestinal infarctions (HP:0005244) | 2.04642169 |
| 67 | Abnormality of T cell physiology (HP:0011840) | 2.04580137 |
| 68 | Keratoconjunctivitis sicca (HP:0001097) | 2.02681702 |
| 69 | Gingivitis (HP:0000230) | 2.02515290 |
| 70 | Genetic anticipation (HP:0003743) | 2.02335028 |
| 71 | Albinism (HP:0001022) | 2.02216343 |
| 72 | Abnormality of binocular vision (HP:0011514) | 2.00091112 |
| 73 | Diplopia (HP:0000651) | 2.00091112 |
| 74 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.00016966 |
| 75 | Anorexia (HP:0002039) | 1.99796933 |
| 76 | Partial agenesis of the corpus callosum (HP:0001338) | 1.99272348 |
| 77 | Abnormality of the fovea (HP:0000493) | 1.97750601 |
| 78 | Epistaxis (HP:0000421) | 1.96256485 |
| 79 | Abnormality of the prostate (HP:0008775) | 1.94353607 |
| 80 | Polyphagia (HP:0002591) | 1.94152070 |
| 81 | Gaze-evoked nystagmus (HP:0000640) | 1.93125063 |
| 82 | Meningitis (HP:0001287) | 1.92010028 |
| 83 | B lymphocytopenia (HP:0010976) | 1.91591018 |
| 84 | Severe visual impairment (HP:0001141) | 1.90678392 |
| 85 | Polycythemia (HP:0001901) | 1.90418173 |
| 86 | Urticaria (HP:0001025) | 1.89322867 |
| 87 | Chronic hepatic failure (HP:0100626) | 1.89270749 |
| 88 | Abnormality of the renal medulla (HP:0100957) | 1.86962582 |
| 89 | Pustule (HP:0200039) | 1.85697298 |
| 90 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.84369251 |
| 91 | Prostate neoplasm (HP:0100787) | 1.82521366 |
| 92 | Cerebral palsy (HP:0100021) | 1.82086812 |
| 93 | Inability to walk (HP:0002540) | 1.81684179 |
| 94 | 3-Methylglutaconic aciduria (HP:0003535) | 1.80543681 |
| 95 | Clumsiness (HP:0002312) | 1.79766490 |
| 96 | Encephalitis (HP:0002383) | 1.79133799 |
| 97 | Tinnitus (HP:0000360) | 1.78573383 |
| 98 | Pendular nystagmus (HP:0012043) | 1.77554393 |
| 99 | Medial flaring of the eyebrow (HP:0010747) | 1.75658678 |
| 100 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.75378943 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.05588696 |
| 2 | ZAK | 2.61452052 |
| 3 | TXK | 2.59613824 |
| 4 | ADRBK2 | 2.59310168 |
| 5 | RIPK4 | 2.57464623 |
| 6 | MAP2K3 | 2.49593040 |
| 7 | GRK6 | 2.46993191 |
| 8 | BLK | 2.34804963 |
| 9 | TAOK3 | 2.31121426 |
| 10 | TLK1 | 2.03763948 |
| 11 | TEC | 1.99626693 |
| 12 | TNK2 | 1.91000644 |
| 13 | SYK | 1.89755429 |
| 14 | GRK1 | 1.84567557 |
| 15 | IRAK4 | 1.81230833 |
| 16 | ACVR1B | 1.80766676 |
| 17 | INSRR | 1.80171255 |
| 18 | BMPR1B | 1.78595994 |
| 19 | PIK3CA | 1.76240135 |
| 20 | DAPK2 | 1.73697657 |
| 21 | PINK1 | 1.66875750 |
| 22 | OXSR1 | 1.58845775 |
| 23 | NUAK1 | 1.53084823 |
| 24 | CAMKK2 | 1.49534298 |
| 25 | MAPK13 | 1.48156889 |
| 26 | MAP4K1 | 1.47658242 |
| 27 | PTK2B | 1.43674534 |
| 28 | WNK3 | 1.41464235 |
| 29 | BTK | 1.35890819 |
| 30 | PIK3CG | 1.31969107 |
| 31 | FES | 1.31368284 |
| 32 | TAOK1 | 1.28066890 |
| 33 | ITK | 1.28020437 |
| 34 | ZAP70 | 1.19817741 |
| 35 | MAP4K2 | 1.18424871 |
| 36 | MAP2K6 | 1.18389051 |
| 37 | LYN | 1.18115853 |
| 38 | MAP3K11 | 1.15369414 |
| 39 | MAP3K6 | 1.07501118 |
| 40 | SIK2 | 1.06904478 |
| 41 | MAP2K4 | 1.02968570 |
| 42 | TRPM7 | 1.02929028 |
| 43 | KIT | 1.02652870 |
| 44 | STK11 | 1.00807125 |
| 45 | IRAK1 | 0.98936134 |
| 46 | IKBKB | 0.96612500 |
| 47 | BRSK2 | 0.96299386 |
| 48 | ADRBK1 | 0.94093715 |
| 49 | HCK | 0.91337150 |
| 50 | HIPK2 | 0.86685577 |
| 51 | WNK4 | 0.86097326 |
| 52 | FGR | 0.85905237 |
| 53 | PRKG2 | 0.83018993 |
| 54 | WNK1 | 0.80602765 |
| 55 | DYRK2 | 0.73446822 |
| 56 | MAP2K1 | 0.73189966 |
| 57 | LCK | 0.72428115 |
| 58 | PRKCQ | 0.71172567 |
| 59 | PAK3 | 0.69807420 |
| 60 | JAK2 | 0.69422008 |
| 61 | GRK5 | 0.69159078 |
| 62 | MAPKAPK3 | 0.63785573 |
| 63 | MARK3 | 0.63378879 |
| 64 | PDK2 | 0.63181590 |
| 65 | EPHA3 | 0.63067458 |
| 66 | NTRK3 | 0.61358532 |
| 67 | CDK19 | 0.61226740 |
| 68 | CSK | 0.59286170 |
| 69 | PRKAA2 | 0.57505549 |
| 70 | IKBKE | 0.56176551 |
| 71 | MAP3K5 | 0.55907871 |
| 72 | TIE1 | 0.55131269 |
| 73 | CSF1R | 0.49702059 |
| 74 | MAP3K3 | 0.47742942 |
| 75 | MAPK12 | 0.46340405 |
| 76 | CASK | 0.45588657 |
| 77 | RPS6KA5 | 0.44669180 |
| 78 | VRK1 | 0.43625877 |
| 79 | GRK7 | 0.42266276 |
| 80 | MAP3K4 | 0.41591236 |
| 81 | MAP2K2 | 0.41531002 |
| 82 | PIM1 | 0.41086183 |
| 83 | MKNK2 | 0.39897517 |
| 84 | MAPK15 | 0.38278863 |
| 85 | RPS6KA6 | 0.38209664 |
| 86 | YES1 | 0.37189859 |
| 87 | PDK1 | 0.36407489 |
| 88 | CLK1 | 0.36002418 |
| 89 | BMPR2 | 0.34490077 |
| 90 | ERBB2 | 0.34148364 |
| 91 | ABL1 | 0.33512639 |
| 92 | FLT3 | 0.33456693 |
| 93 | DYRK1A | 0.32914440 |
| 94 | CSNK1G2 | 0.32782588 |
| 95 | PRKCG | 0.32638364 |
| 96 | PRKAA1 | 0.32163426 |
| 97 | EIF2AK2 | 0.31017757 |
| 98 | PRKCZ | 0.30098792 |
| 99 | PRKG1 | 0.29263005 |
| 100 | MAPKAPK5 | 0.27598987 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.19128986 |
| 2 | Asthma_Homo sapiens_hsa05310 | 2.79107626 |
| 3 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.71801979 |
| 4 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.42183043 |
| 5 | Malaria_Homo sapiens_hsa05144 | 2.38501395 |
| 6 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.21483024 |
| 7 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.08791058 |
| 8 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.00554466 |
| 9 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.97814946 |
| 10 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.97323170 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.97192016 |
| 12 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.95506340 |
| 13 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.90741955 |
| 14 | Phototransduction_Homo sapiens_hsa04744 | 1.79315633 |
| 15 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.71224166 |
| 16 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.70649074 |
| 17 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.68938148 |
| 18 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.65300937 |
| 19 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.64358387 |
| 20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.63794466 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.57205499 |
| 22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.56320326 |
| 23 | Olfactory transduction_Homo sapiens_hsa04740 | 1.45180343 |
| 24 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.40846671 |
| 25 | Morphine addiction_Homo sapiens_hsa05032 | 1.39679922 |
| 26 | Tuberculosis_Homo sapiens_hsa05152 | 1.34314028 |
| 27 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.29330653 |
| 28 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.27926665 |
| 29 | Leishmaniasis_Homo sapiens_hsa05140 | 1.27791723 |
| 30 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.27690788 |
| 31 | Legionellosis_Homo sapiens_hsa05134 | 1.25023218 |
| 32 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.24000983 |
| 33 | ABC transporters_Homo sapiens_hsa02010 | 1.23477084 |
| 34 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.19502182 |
| 35 | Salivary secretion_Homo sapiens_hsa04970 | 1.14983246 |
| 36 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.14951216 |
| 37 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.13436153 |
| 38 | Lysosome_Homo sapiens_hsa04142 | 1.11942404 |
| 39 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.11147772 |
| 40 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.06808928 |
| 41 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.05757609 |
| 42 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.05684082 |
| 43 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.05334415 |
| 44 | Platelet activation_Homo sapiens_hsa04611 | 1.03965486 |
| 45 | Nicotine addiction_Homo sapiens_hsa05033 | 1.03893454 |
| 46 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.97142459 |
| 47 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.90793504 |
| 48 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.89174255 |
| 49 | GABAergic synapse_Homo sapiens_hsa04727 | 0.88615154 |
| 50 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.86705422 |
| 51 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.86509640 |
| 52 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.86096149 |
| 53 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.86013641 |
| 54 | Taste transduction_Homo sapiens_hsa04742 | 0.86010854 |
| 55 | Circadian entrainment_Homo sapiens_hsa04713 | 0.85011381 |
| 56 | Phagosome_Homo sapiens_hsa04145 | 0.82918792 |
| 57 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.81469483 |
| 58 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.81238842 |
| 59 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.78441848 |
| 60 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.78418127 |
| 61 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.75015458 |
| 62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.74130048 |
| 63 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.72803436 |
| 64 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.72132614 |
| 65 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.70530752 |
| 66 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.70292784 |
| 67 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.70126989 |
| 68 | Parkinsons disease_Homo sapiens_hsa05012 | 0.69852601 |
| 69 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.69808441 |
| 70 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.68731768 |
| 71 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.68681828 |
| 72 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.68636969 |
| 73 | Peroxisome_Homo sapiens_hsa04146 | 0.68227560 |
| 74 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.64809261 |
| 75 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.64332530 |
| 76 | Homologous recombination_Homo sapiens_hsa03440 | 0.63809902 |
| 77 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.63527752 |
| 78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.63155519 |
| 79 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.61439744 |
| 80 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.61053894 |
| 81 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.54754336 |
| 82 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.49327833 |
| 83 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.49269375 |
| 84 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48169504 |
| 85 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.43812908 |
| 86 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.43719171 |
| 87 | Insulin secretion_Homo sapiens_hsa04911 | 0.43708598 |
| 88 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.43683424 |
| 89 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.43493570 |
| 90 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.40980320 |
| 91 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.40831245 |
| 92 | Allograft rejection_Homo sapiens_hsa05330 | 0.39709340 |
| 93 | Pertussis_Homo sapiens_hsa05133 | 0.39267375 |
| 94 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.38367015 |
| 95 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.37425975 |
| 96 | Protein export_Homo sapiens_hsa03060 | 0.35403612 |
| 97 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.33558380 |
| 98 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.33212118 |
| 99 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.32782055 |
| 100 | Long-term depression_Homo sapiens_hsa04730 | 0.31995304 |

